• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azetidines

Recent Advances in the Study of 3-(2-methylpropoxy)azetidine (CAS: 1260879-20-6) in Chemical Biology and Pharmaceutical Research

3-(2-methylpropoxy)azetidine (CAS: 1260879-20-6) has emerged as a compound of significant interest in chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. Recent studies have focused on its synthesis, pharmacological activity, and mechanism of action, providing valuable insights for drug discovery and development. This research brief aims to summarize the latest findings related to this compound, highlighting its potential in addressing unmet medical needs.

The synthesis of 3-(2-methylpropoxy)azetidine has been optimized in recent studies to improve yield and purity, which are critical for its application in drug development. Advanced techniques such as asymmetric synthesis and catalytic hydrogenation have been employed to achieve high enantiomeric purity, a key factor in its pharmacological efficacy. These methodological advancements have paved the way for scalable production, making the compound more accessible for further research and clinical applications.

Pharmacological studies have revealed that 3-(2-methylpropoxy)azetidine exhibits promising activity as a modulator of specific biological targets, including G-protein-coupled receptors (GPCRs) and ion channels. Its ability to interact with these targets suggests potential applications in treating neurological disorders, cardiovascular diseases, and inflammatory conditions. Recent in vitro and in vivo studies have demonstrated its efficacy in modulating receptor activity with high specificity, reducing off-target effects commonly associated with similar compounds.

In addition to its pharmacological properties, the compound's pharmacokinetic profile has been extensively studied. Research indicates that 3-(2-methylpropoxy)azetidine has favorable absorption, distribution, metabolism, and excretion (ADME) characteristics, enhancing its suitability as a drug candidate. Its metabolic stability and low toxicity profile further support its potential for clinical development. These findings are particularly relevant for designing dosage forms and administration regimens in future clinical trials.

Recent collaborations between academic institutions and pharmaceutical companies have accelerated the exploration of 3-(2-methylpropoxy)azetidine's therapeutic potential. Preclinical studies are currently underway to evaluate its efficacy in disease models, with preliminary results showing promise in areas such as pain management and neurodegenerative diseases. These efforts underscore the compound's versatility and its potential to address a broad spectrum of medical conditions.

In conclusion, 3-(2-methylpropoxy)azetidine (CAS: 1260879-20-6) represents a promising candidate for further drug development, with its optimized synthesis, targeted pharmacological activity, and favorable pharmacokinetic profile. Ongoing research is expected to elucidate its full therapeutic potential, paving the way for its translation into clinical applications. The compound's unique properties position it as a valuable asset in the quest for innovative treatments in chemical biology and pharmaceutical sciences.

• 1219976-56-3(3-(Cyclopropylmethoxy)azetidine)
• 1254645-35-6(3-cyclopropoxyazetidine)
• 1147530-63-9(3-(Tert-butoxy)azetidine)
• 1219982-44-1(3-(3-Methoxypropoxy)azetidine)
• 1220038-78-7(3-(2-Propoxyethoxy)azetidine)
• 88536-21-4(3-Ethoxyazetidine)
• 1309207-99-5(3-(2-methylpropoxy)azetidine hydrochloride)
• 897019-55-5(3-Propoxy-azetidine Hydrochloride)
• 871791-79-6(3-Isopropoxy-azetidine)
• 897086-92-9(3-propoxyazetidine)